Haemonetics Corp. (HAE) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $85.82 -0.46%
Revenue Growth %: +8.4%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +8.4%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Procter & Gamble (PG) PT Raised to $185 at Argus
- Equinor ASA (EQNR) Tops Q1 EPS by 22c, misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
